Business
Target Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™
Target Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™.
About this update from Target Group Inc.
[{"type":"text","content":"\n\n\n\nTarget Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTarget Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™\nPR Newswire\nVAUGHAN, ON, Aug. 13, 2019\n\n\n\nVAUGHAN, ON, Aug. 13, 2019 /PRNewswire/ - Target Group Inc. (\"Target Group\" or the \"Company\") (OTCQB: CBDY) is pleased to announce, that effective August 8, 2019, it has entered into an exclusive licensing, manufacturing and distribution agreement with cGreen Inc. for a period of 10 years. The agreement permits Target Group to manufacture and distribute the patent-pending THC antidote, True Focus™, in the United States, Europe and the Caribbean. \n\n \n \n\n \nThe exclusive licensing agreement grants Target Group the rights to the complete True Focus™ intellectual property portfolio, including use of the \"True Focus™\" trade name, trademarks, logos and art, rights to product formulations, methods and processes. The agreement will facilitate the expansion of Target Group's growing wellness portfolio and position the Company for global manufacturing and distribution.\nExcessive cannabis consumption may lead to adverse and unwanted side effects. True Focus' all-natural, nutraceutical formulation offers a unique solution to rapidly alleviate the undesirable effects associated with over-consumption of tetrahydrocannabinol (\"THC\"). True Focus' innovative THC antidote is dispensed sublingually via a discreet, pocket-sized spray bottle. True Focus' product formulations are considered 'patent-pending' by way of a United States Patent and Trademark Office (\"USPTO\") application.\n\"The True Focus agreement will enable Target Group to enter legal, international markets around the globe, and to develop a centralized distribution channel for its suite of wellness products. This partnership also accelerates Target Group's ability to generate revenue within the broader American, European...